0001415889-21-002003.txt : 20210414 0001415889-21-002003.hdr.sgml : 20210414 20210414193415 ACCESSION NUMBER: 0001415889-21-002003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210412 FILED AS OF DATE: 20210414 DATE AS OF CHANGE: 20210414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schueren Robert Alan CENTRAL INDEX KEY: 0001597341 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 21826965 MAIL ADDRESS: STREET 1: 7400 PASEO PADRE PARKWAY CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-04142021_040403.xml X0306 4 2021-04-12 0001604821 Natera, Inc. NTRA 0001597341 Schueren Robert Alan C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 false true false false CHIEF OPERATING OFFICER Common Stock 2021-04-12 4 M 0 43990 A 50972 D Common Stock 2021-04-13 4 S 0 22093 104.2125 D 28879 D Common Stock 2021-04-13 4 M 0 1281 13.01 A 30160 D Common Stock 52637 I Robert A Schueren & Deborah A Schueren Rev Trust Restricted Stock Units 2021-04-12 4 M 0 43990 0 D Common Stock 43990 0 D Stock Option (right to buy) 13.01 2021-04-13 4 M 0 1281 0 D 2029-01-10 Common Stock 1281 64601 D Represents the full vesting and settlement of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the issuer. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1. The RSUs vested upon the determination of the issuer's Compensation Committee to vest the award, subject to trading restrictions on the underlying shares. The option shares vest over four years. 25% of the option shares vested and became exercisable on January 7, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Tami Chen, Attorney-in-Fact 2021-04-14